Piramal Pharma Limited (PPLPHARMA) Share Price & AI Investment Analysis

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing; offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain management drugs, and other generic and speciality products; and anal. Track Piramal Pharma Limited's live NSE:PPLPHARMA share price ₹210.74 (+0.37%), market cap ₹₹279B. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for PPLPHARMA — real-time NSE India stock intelligence.